| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
3 companies
Bohlin Garen G is a Director at COLLEGIUM PHARMACEUTICAL, INC with holdings across 3 companies. Recent SEC Form 4 filings include 2 buys and 1 sell.
Estimated insider holdings value: $3.0M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| May 14, 2024 | COLL Collegium Pharmaceutical, Inc | Director | Sale+OE | 28,985 | $32.30 | $936,311.15 | -39.3% | +7.0% | -12.7% | |
| Sep 12, 2023 | KPTI Karyopharm Therapeutics Inc. | Director | Buy | 41,140 | $1.22 | $49,985.10 | +1,029% | -39.7% | -43.0% | |
| May 6, 2021 | KPTI Karyopharm Therapeutics Inc. | Director | Buy | 4,000 | $7.82 | $31,280.00 | New | -3.9% | -25.3% |